LRRC63 Activators
LRRC63 Activators encompass a diverse group of chemical compounds that indirectly augment the functional activity of LRRC63 through various signaling pathways. Compounds like Forskolin and Epigallocatechin gallate (EGCG) play pivotal roles in modulating intracellular signaling cascades. Forskolin, by elevating cAMP levels, activates PKA, which can phosphorylate substrates in LRRC63-related pathways, thereby enhancing LRRC63's activity. Similarly, EGCG, by inhibiting various kinases, reduces competitive signaling, potentially favoring LRRC63-involved pathways. Sphingosine-1-phosphate and Thapsigargin, through modulating lipid and calcium signaling respectively, alter the cellular environment to favor LRRC63's activity. Thapsigargin, by inhibiting SERCA, increases intracellular calcium levels, thus activating pathways in which LRRC63 might be involved. A23187 further contributes to this by elevating calcium levels, enhancing calcium-dependent pathways linked with LRRC63.
Additionally, kinase inhibitors like U0126 and SB203580 selectively target components of the MAPK pathway, altering signaling dynamics to potentially enhance LRRC63's role in these pathways. U0126 inhibits MEK1/2, while SB203580 targets p38 MAPK, both contributing to a shift in cellular signaling that may indirectly favor LRRC63 activation. Genistein's role as a tyrosine kinase inhibitor parallels this mechanism, reducing competitive signaling from tyrosine kinases, thereby indirectly supporting LRRC63 pathways. PMA and Wortmannin also contribute significantly to the modulation of LRRC63 activity. PMA, by activating PKC, influences numerous signaling pathways, potentially enhancing those involving LRRC63. Wortmannin, through its potent inhibition of PI3K, indirectly fosters an environment conducive to LRRC63's functional enhancement by reducing PI3K/Akt pathway activity. Collectively, these LRRC63 Activators, through their targeted effects on various cellular signaling processes, facilitate the functional enhancement of LRRC63 without the need for its direct activation or upregulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a polyphenol compound found in green tea, influences LRRC63 indirectly through its inhibitory effects on various kinases. By inhibiting these kinases, EGCG reduces competitive signaling pathways, thereby potentially enhancing the pathways in which LRRC63 is involved. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a specific inhibitor of PI3K, modulates the PI3K/Akt pathway. By inhibiting this pathway, it can enhance the activity of LRRC63, which may be regulated negatively by PI3K signaling. The suppression of PI3K thus indirectly enhances LRRC63's function in its respective pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate, a lipid signaling molecule, influences LRRC63 by modulating sphingolipid pathways. It can activate sphingosine kinase, leading to changes in cellular signaling that indirectly enhance the functional activity of LRRC63 by altering the intracellular environment in which LRRC63 operates. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a broad-spectrum protein kinase inhibitor, may enhance LRRC63 activity by inhibiting kinases that negatively regulate LRRC63 pathways. By reducing these inhibitory signals, Staurosporine can indirectly increase LRRC63 activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin, a sesquiterpene lactone, elevates intracellular calcium levels by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA). Elevated calcium can activate calcium-dependent signaling pathways, which may include pathways where LRRC63 is active, thus indirectly enhancing LRRC63's activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187, a calcium ionophore, increases intracellular calcium levels, influencing calcium-dependent signaling pathways. This alteration in calcium signaling can enhance LRRC63 activity indirectly by modifying the signaling environment in which LRRC63 operates. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, a selective inhibitor of MEK1/2, influences the MAPK/ERK pathway. By inhibiting this pathway, it may indirectly enhance LRRC63's functional activity by shifting signaling dynamics in favor of pathways where LRRC63 is involved. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a specific inhibitor of p38 MAPK, modulates the MAPK pathway. This modulation can indirectly enhance LRRC63 activity by altering the balance of cellular signaling pathways, potentially favoring those in which LRRC63 plays a role. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, an isoflavone derived from soy products, functions as a tyrosine kinase inhibitor. By inhibiting these kinases, Genistein can enhance LRRC63 activity by reducing competition from tyrosine kinase signaling, thereby indirectly favoring pathways involving LRRC63. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, an activator of protein kinase C (PKC), indirectly enhances LRRC63 activity by activating PKC which influences various cellular signaling pathways. This activation can shift the cellular signaling balance, potentially enhancing pathways in which LRRC63 is involved. | ||||||